Stryker to recall hip implants at a cost of $1.13B:

It’s not so easy to recall a product that has been implanted in an individual’s body. This is the case with Stryker Corp., maker of medical devices who expects to spend about $1.13B to resolve litigation and other costs related to the product recall. Stryker recalled the Rejuvenate and ABG II hip implants from the market last year due to the potential for corrosion, which causes pain and swelling for patients. About 20,000 of these devices have been implanted into patients in the U.S. alone, where Stryker will be expected to reimburse patients for medical costs.